MedTrace Logo

Self-Care for Dementia Caregivers

NCT05309577 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2026-01-23

Study results available
· View outcomes & findings →

Summary

The Self-care for Dementia Caregivers Study is a behavioral health intervention that uses digital monitoring tools and motivational health coaching to help caregivers of persons with dementia engage in a regular routine of sleep and activity. Participants wear an apple watch for the objective collection of sleep-wake rhythms. They receive personalized feedback on their sleep-wake rhythms via a new app. Health coaches call participants weekly, for up to 6 weeks to help participants meet their health/sleep goals and promote self-knowledge of regular routines. Participants will help the study team improve the design elements and content of the mobile app. The goal of this intervention is to reduce depressive and insomnia symptoms.

Conditions

  • Aging
  • Mental Disorder
  • Eating, Healthy
  • Physical Inactivity
  • Prodromal Symptoms
  • Sleep
  • Alzheimer Disease
  • Dementia
  • Circadian Rhythm Disorders

Interventions

BEHAVIORAL

Behavioral Self-Monitoring + Motivational Interviewing

Participants (n=20) will wear a iWatch to continuously measure their objective sleep-wake activity. The iWatch data sync to the new myRhythmWatch app, where participants will monitor their behavioral rhythm. Participants will also interact with a 'health coach' about their recorded behaviors weekly. This health coach will use motivational interviewing to enhance older adult caregivers' confidence and intrinsic motivation to engage in regular self-care.

Sponsors & Collaborators

  • National Institute on Aging (NIA)

    collaborator NIH

  • Activity Rhythm Solutions Corporation

    collaborator UNKNOWN

  • Oregon Health and Science University

    collaborator OTHER

  • University of Pittsburgh

    lead OTHER

Principal Investigators

  • Sarah T Stahl, PhD · University of Pittsburgh, Assistant Professor of Psychiatry and Clinical and Translational Science

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
50 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-03-07
Primary Completion
2024-12-01
Completion
2025-03-10

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05309577 on ClinicalTrials.gov